Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,469 | 511 | 97.1% |
| Education | $282.36 | 14 | 2.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,574 | 88 | $0 (2024) |
| Amarin Pharma Inc. | $1,285 | 101 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $1,185 | 71 | $0 (2024) |
| Novo Nordisk Inc | $827.91 | 44 | $0 (2024) |
| Astellas Pharma US Inc | $522.91 | 27 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $487.39 | 20 | $0 (2019) |
| Allergan Inc. | $428.80 | 20 | $0 (2019) |
| Kowa Pharmaceuticals America, Inc. | $384.02 | 21 | $0 (2024) |
| PFIZER INC. | $368.38 | 17 | $0 (2024) |
| Amgen Inc. | $333.93 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,748 | 69 | GlaxoSmithKline, LLC. ($394.92) |
| 2023 | $1,132 | 49 | GlaxoSmithKline, LLC. ($300.19) |
| 2022 | $1,152 | 58 | GlaxoSmithKline, LLC. ($230.17) |
| 2021 | $1,110 | 69 | Amarin Pharma Inc. ($312.07) |
| 2020 | $450.52 | 34 | Amarin Pharma Inc. ($205.59) |
| 2019 | $1,249 | 75 | Janssen Pharmaceuticals, Inc ($438.52) |
| 2018 | $1,201 | 76 | AstraZeneca Pharmaceuticals LP ($169.40) |
| 2017 | $1,709 | 95 | Allergan Inc. ($393.83) |
All Payment Transactions
525 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: Diabetes | ||||||
| 12/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $5.33 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: DIABETES | ||||||
| 12/03/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: DERMATOLOGY | ||||||
| 11/25/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: Diabetes | ||||||
| 11/08/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $10.03 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/07/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: Cardio-renal | ||||||
| 10/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: RESPIRATORY | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: Respiratory | ||||||
| 10/14/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/14/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $2.73 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/11/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $10.44 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/07/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Diabetes | ||||||
| 10/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: RESPIRATORY | ||||||
| 10/03/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $8.40 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: RESPIRATORY | ||||||
| 09/19/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $112.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/18/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $123.55 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 669 | 1,309 | $144,131 | $71,168 |
| 2022 | 14 | 611 | 1,207 | $130,754 | $66,166 |
| 2021 | 13 | 602 | 1,336 | $146,842 | $76,521 |
| 2020 | 13 | 749 | 1,709 | $150,990 | $70,387 |
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 114 | 326 | $40,424 | $18,239 | 45.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 86 | 196 | $34,692 | $17,189 | 49.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 78 | 78 | $17,550 | $9,557 | 54.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 26 | 72 | $11,985 | $6,476 | 54.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 23 | 32 | $6,880 | $4,241 | 61.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 22 | 54 | $7,650 | $3,289 | 43.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 12 | 14 | $5,670 | $2,923 | 51.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 20 | $3,400 | $2,490 | 73.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 21 | 24 | $3,120 | $2,108 | 67.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 45 | 45 | $1,125 | $1,103 | 98.0% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 46 | 46 | $1,380 | $941.16 | 68.2% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 61 | 241 | $3,615 | $773.61 | 21.4% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 17 | 19 | $1,710 | $727.37 | 42.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 34 | 45 | $2,700 | $472.09 | 17.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 20 | 36 | $1,440 | $350.13 | 24.3% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 35 | 49 | $490.00 | $193.06 | 39.4% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 11 | 12 | $300.00 | $96.70 | 32.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 122 | 360 | $63,693 | $29,957 | 47.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 101 | 239 | $29,636 | $14,784 | 49.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 39 | 57 | $9,690 | $7,491 | 77.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 51 | 51 | $11,370 | $6,317 | 55.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 19 | 19 | $4,240 | $3,081 | 72.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 20 | 23 | $2,070 | $1,100 | 53.1% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2022 | 56 | 56 | $1,680 | $1,084 | 64.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 33 | 33 | $825.00 | $808.50 | 98.0% |
About Dr. Rasheed Nemer, MD
Dr. Rasheed Nemer, MD is a Internal Medicine healthcare provider based in Akron, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1467441469.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rasheed Nemer, MD has received a total of $9,752 in payments from pharmaceutical and medical device companies, with $1,748 received in 2024. These payments were reported across 525 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($9,469).
As a Medicare-enrolled provider, Nemer has provided services to 2,631 Medicare beneficiaries, totaling 5,561 services with total Medicare billing of $284,242. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Akron, OH
- Active Since 10/21/2005
- Last Updated 01/20/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1467441469
Products in Payments
- Vascepa (Drug) $1,285
- TRELEGY ELLIPTA (Drug) $693.21
- Ozempic (Drug) $512.03
- BREZTRI (Drug) $457.47
- SYMBICORT (Drug) $431.11
- AREXVY (Drug) $415.93
- XARELTO (Drug) $392.96
- ELIQUIS (Drug) $376.28
- Livalo (Drug) $370.70
- VOQUEZNA (Drug) $311.49
- TOUJEO (Drug) $302.10
- JARDIANCE (Drug) $237.00
- ENTRESTO (Drug) $215.87
- KRYSTEXXA (Biological) $210.74
- ANORO (Drug) $185.33
- Myrbetriq (Drug) $181.89
- VIBERZI (Drug) $171.38
- Rybelsus (Drug) $163.77
- TRULANCE (Drug) $142.01
- AIRSUPRA (Drug) $126.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Akron
Hassan Malik, Md, MD
Internal Medicine — Payments: $1.6M
Dr. Amy Hite, M.d, M.D
Internal Medicine — Payments: $274,260
Dr. Mark Arredondo, Md, MD
Internal Medicine — Payments: $214,747
Dr. Kenneth Varian, Md, Phd, MD, PHD
Internal Medicine — Payments: $143,561
Dr. Ganesh Veerappan, Md, MD
Internal Medicine — Payments: $114,341
Laurie Matt-Amaral, M.d, M.D
Internal Medicine — Payments: $25,139